ADVERTISEMENT FDA-Nixed Language Can Be In Drug Promos, Expert Testifies Law360 (July 19, 2021, 9:29 PM EDT) -- A former FDA official testified in a California opioid trial Monday that it would not necessarily be a problem if drugmaker Endo's promotional material included a phrase that regulators had demanded be taken out of the product's official label. Minnie Baylor-Henry, the director from 1995 to 1999 of the U.S. Food and Drug Administration's Division of Drug Marketing, Advertising, and Communications — or DDMAC — spent nearly a day on the stand as an expert witness for Endo, one of the drugmakers defending against four California jurisdictions' claims that they ushered addictive drugs into the health care ecosystem and created a...